Kristian’s background is in project management and administration in international development settings, and his role within the group is the coordination and management of the group’s grants. 

Follow Kristian on Twitter at: @kg_se10.

In her role as Programme Coordinator, Christina provides administrative, logistical and financial management support for the group. Christina joined LSHTM in 2014 as a Programme Manager based at the London International Development Centre, and since that time has worked on a variety of projects within the School. Her earlier roles at Imperial College London and the MRC Clinical Trials Unit were also in programme management and administration.

Miyo works as a Programme Coordinator, providing administrative, logistical and financial management support for the group. Her background is in international development management and prior to joining LSHTM in 2017, she worked for various ODA projects in Latin America and Asia primarily in the field of higher education.

Richard's research focus is the mathematical and statistical modelling of the transmission and control of infectious diseases, particularly TB and HIV. He co-leads the TB modelling group and has a broad interest in the use of models to better understand the transmission, prevention, and care of TB. He has particular interests in the use of models to improve TB prevention and care decision making at global and country level, and to accelerate the development of new TB vaccines.

Follow Richard on Twitter at: @richardwhite321.

Rein is a TB epidemiologist and mathematical modeller. He co-leads the TB modelling group, where his primary research focus is the natural history of TB, in particular the dynamic spectrum of infection and disease as part of an ERC Starting Grant. In addition Rein has a wide interest in informing TB policy as well as understanding the social and structural determinants of TB.  Follow Rein on Twitter at: @Rein_Houben.

Gwen's research focuses on the spread of antibiotic resistance: by understanding where it comes from can we design novel methods for control? She has worked on estimating the fitness costs of resistance in TB, the impact of vaccination and estimates of the latent burden of drug-resistant TB infection. 

Follow Gwen on Twitter at: @gmknght.

Emilia works at Public Health England (PHE) and has an affiliation with LSHTM. She works on modelling infectious diseases with a focus on rubella and TB. Her current TB research interest includes the effect of diagnstic delays.

Finn is interested in modelling drug resistant TB, the impact of COVID-19 on TB and treatment adherence technology. He is also the secretariat epidemiologist for the TB Modelling and Analysis Consortium (TB MAC). His background is in maths.

Follow Finn on Twitter at: @cfmcquaid.

Tom is interested in using models to predict and understand the impact of interventions. His current work is focused on active case finding and the potential impact of new TB vaccines.

Nicky is interested in understanding the role of heterogeneity (e.g. in contact patterns, infectiousness, natural history, and health seeking behaviour) in the transmission and control of TB. She also works on calibration methodology.

Katherine is an epidemiologist and mathematical modeller interested understanding and addressing disparities that increase TB burden and limit access to diagnosis and treatment.

Follow Katharine on Twitter at: @kc_horton.

Kiesha is an infectious disease modeller at LSHTM and the Saw Swee Hock School of Public Health at the National University of Singapore. She collaborates closely with the national TB programme in Cambodia and Singapore to evaluate the health impact and cost-effectiveness of TB active case-finding strategies.  Follow Kiesha on Twitter at: @kiesha_prem.

Rebecca is a vaccine epidemiologist and mathematical modeller. Her research focusses on modelling to inform development and implementation of new and existing TB vaccines, with the goal of informing development of candidates with the greatest potential for future public health impact. Other areas of interest have included modelling the impact of COVID-19 on TB, and development and evaluation of an app (ePAL) for spatial mapping of patients in highly populous low-income settings without addresses.

Follow Rebecca on Twitter at: @RebeccaCHarris.

Matt is a health economist, interested in combining health economics and infectious disease modelling to understand and solve public health problems. He is currently working on TB modelling studies estimating the impact, cost-effectiveness, and equity impact of TB vaccines and digital adherence technologies.

Follow Matthew on Twitter at: @matthew_quaife. 

Nicola's research is focused on the measurement and analysis of the social determinants of tuberculosis. Her background is in pharmacy, public health and health economics. 

Follow Nicola on Twitter at: @nicola_c_foster.

Jon is a mathematical modeller of infectious diseases. His research focuses on using modelling methods to infer the underlying natural history of TB from empirical data, before using the results to inform intervention strategies designed to prevent progression to TB disease. 

Follow Jon on Twitter at: @JonCEmery.

Danny is interested on the calibration of complex individual-based stochastic models. In particular, he is involved in a project to develop a history matching and model emulation R package. He also works with social contact data, with the aim of understanding Mtb transmission patterns.

Follow Danny on Twitter at: @DannyScarponi.

Debora is a TB epidemiologist and health economist currently based at the Special Programme for Research and Training in Tropical Diseases (TDR) at the World Health Organization. Her primary research interest is in expanding the evidence base on the socioeconomic determinants of TB, through the evaluation of mechanisms to increase health care coverage, financial and social protection among people with TB.

Lara is a mathematical modeller of infectious diseases, her main research interest is studying transmission mechanisms and population dynamics. She mostly works on TB modelling and cost-effectiveness analysis.

Alex is a research degree student with an interest in modelling the natural history of tuberculosis with a focus on subclinical disease. Her background is in maths, physics, and epidemiology.

Follow Alex on Twitter at: @alexsrichards.

Rebecca is a research degree student interested in modelling tuberculosis vaccine implementation strategies both nationally and subnationally. Her background is in math, statistics, and epidemiology.

Follow Rebecca on Twitter at: @ra_clark18.

Martin is a health economist and research degree student. He is looking at modelling the potential effectiveness of preventive therapies for multidrug-resistant TB. His background is in biological sciences, maths and public health.

Naomi is a research degree student at LSHTM looking at using mathematical models built with parameters from experiments (UCL) to improve our understanding of drug resistant TB. Her background is in physics.

Follow Naomi on Twitter at: @naomimfuller.

Kate is a research degree student at LSHTM interested in modelling the impact of
interventions on TB transmission. Her background is in geospatial epidemiology
and medical anthropology. Follow Kate on Twitter at: @klegrand15.

Alvaro is a research degree student at LSHTM working on tuberculosis burden estimation. His background is in medicine and epidemiology. Follow Alvaro on Twitter at: @aschwalbc.

Puck is an infectious disease epidemiologist specializing in TB and vaccines. At LSHTM she explores implementation strategies for late-stage tuberculosis vaccine candidates with the aim of helping inform epidemiological mathematical modelling and health economic research. She currently runs the TIME model at KNCV.

Follow Puck on Twitter at: @PT_Pelzer.

Christina was a TB Modelling group administrator. She moved to a project administrator role within the School.

John did a PhD with the group, researching the application of PK/PD methods to vaccine dose optimisation

Sean did a PhD project with the group on TB contact tracing in the UK. He started a postdoc at the University of Notre Dame, USA in 2018.

Madeleine worked as part of the TB Modelling and Analysis Consortium secretariat. She left to take up a PhD position at the University of St Andrews

Arminder worked on projects on ventilation and TB vaccine modelling. She left in 2021 to take up a position as a Senior Epidemiologist at CEPI.

Pete worked on TB/HIV modelling within the group. He left to join the School of Health and Related Research at Sheffield University.

Marek worked on the TIME project, supporting country-level TB policy decisions. He left in 2019 to work for the World Health Organization as a Technical Officer in the TB Monitoring, Evaluation and Strategic Information Unit of the Global TB Programme.

Adrienne did a PhD in TB modelling as part of the group. She moved on to a Senior Research Associate role at HEOR & Strategic Market Access (Greater Boston, USA).

Natascha did a PhD on bovine TB. She went on to do a postdoc at the University of Edinburgh.

Christinah worked on TB vaccine modelling. She left in 2022 to take up a position at CEPI

Deborah worked on expanding the evidence base on the socioeconomic determinants of TB. She left to work at the Special Programme for Research and Training in Tropical Diseases (TDR) at the World Health Organization.

Sophie worked on mathematical modelling to inform vaccine dosing decisions. She left the group in 2021 and now works for Certara as a pharmacometric consultant.

Olivia was a TB Modelling group administrator. She went on to be a sports fitness trainer and social media star.

Jamie worked on the TIME project, supporting country-level TB policy decisions. He left the School in 2020, but continues to work as a consultant in TIME modelling.

Tina was a TB Modelling group administrator. She left in 2018 to be a Project Manager at Stellenbosh University in South Africa.

Nabila worked on multiple projects within the group ranging from subclinical disease research to country level TB epidemiology. She left the group in 2021 to work on the COVID-19 medical evidence generation team at Sanofi.

Chathika worked on on the probable impact of new TB vaccines, their cost-effectiveness and their impact of multi-drug resistance. He left the School to work as a Principle Data Scientist at GSK, UK.